BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22907471)

  • 1. Quality of life in children and adolescents with growth hormone deficiency: association with growth hormone treatment.
    Geisler A; Lass N; Reinsch N; Uysal Y; Singer V; Ravens-Sieberer U; Reinehr T
    Horm Res Paediatr; 2012; 78(2):94-9. PubMed ID: 22907471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiency.
    Lagrou K; Xhrouet-Heinrichs D; Massa G; Vandeweghe M; Bourguignon JP; De Schepper J; de Zegher F; Ernould C; Heinrichs C; Malvaux P; Craen M
    J Pediatr Endocrinol Metab; 2001; 14 Suppl 5():1249-60; discussion 1261-2. PubMed ID: 11964020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?
    Colmenares A; González L; Gunczler P; Lanes R
    J Pediatr Endocrinol Metab; 2012; 25(7-8):651-7. PubMed ID: 23155689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life in transition phase in adolescents and young adults with severe and partial growth hormone deficiency.
    Oswiecimska JM; Roczniak W; Romanowicz D; Szymlak A; Mikolajczak A; Malczyk Z; Stojewska M; Ziora KT
    Neuro Endocrinol Lett; 2014; 35(8):676-83. PubMed ID: 25702295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life in children and adolescents with growth hormone deficiency and their caregivers: an Italian survey.
    Maghnie M; Orso M; Polistena B; Cappa M; Pozzobon G; d'Angela D; Patti G; Spandonaro F; Granato S; Di Virgilio R; La Torre D; Salerno M
    J Endocrinol Invest; 2023 Dec; 46(12):2513-2523. PubMed ID: 37209402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary IGF-I deficiency as a prognostic factor of growth hormone (GH) therapy effectiveness in children with isolated, non-acquired GH deficiency.
    Smyczyńska J; Stawerska R; Hilczer M; Lewiński A
    Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):209-14. PubMed ID: 25607339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing immigrant children with native Greek in self-reported-Quality of Life.
    Rotsika V; Vlassopoulos M; Kokkevi A; Fragkaki I; Anagnostopoulos DC; Lazaratou H; Ginieri-Coccossis M
    Psychiatriki; 2016; 27(1):37-43. PubMed ID: 27110881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone treatment and health-related quality of life in children and adolescents: A national, prospective, one-year controlled study.
    Butler G; Turlejski T; Wales G; Bailey L; Wright N
    Clin Endocrinol (Oxf); 2019 Aug; 91(2):304-313. PubMed ID: 31077606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life in congenital, untreated, lifetime isolated growth hormone deficiency.
    Barbosa JA; Salvatori R; Oliveira CR; Pereira RM; Farias CT; Britto AV; Farias NT; Blackford A; Aguiar-Oliveira MH
    Psychoneuroendocrinology; 2009 Jul; 34(6):894-900. PubMed ID: 19181452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial.
    Arends NJ; Boonstra VH; Mulder PG; Odink RJ; Stokvis-Brantsma WH; Rongen-Westerlaken C; Mulder JC; Delemarre-Van de Waal H; Reeser HM; Jansen M; Waelkens JJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):779-87. PubMed ID: 14974922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to growth hormone treatment in isolated growth hormone deficiency versus multiple pituitary hormone deficiency.
    Darendeliler F; Lindberg A; Wilton P
    Horm Res Paediatr; 2011; 76 Suppl 1():42-6. PubMed ID: 21778748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect on adult height of pubertal growth hormone retesting and withdrawal of therapy in patients with previously diagnosed growth hormone deficiency.
    Zucchini S; Pirazzoli P; Baronio F; Gennari M; Bal MO; Balsamo A; Gualandi S; Cicognani A
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4271-6. PubMed ID: 16912138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life in adolescents born small for gestational age: does growth hormone make a difference?
    Bannink EM; van Pareren YK; Theunissen NC; Raat H; Mulder PG; Hokken-Koelega AC
    Horm Res; 2005; 64(4):166-74. PubMed ID: 16205095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
    Feigerlová E; Diene G; Oliver I; Gennero I; Salles JP; Arnaud C; Tauber M
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4600-8. PubMed ID: 20926543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of Life of SGA Children with Short Stature Receiving GH Treatment in Japan.
    Takahashi R; Ogawa M; Osada H
    Pediatr Endocrinol Rev; 2017 Mar; 14 Suppl 1(Suppl 1):222-228. PubMed ID: 28516750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effect sizes of growth hormone replacement on Quality of Life, well-being and health status in growth hormone deficient patients: a meta-analysis.
    Deijen JB; Arwert LI; Witlox J; Drent ML
    Health Qual Life Outcomes; 2005 Oct; 3():63. PubMed ID: 16236167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children.
    Cohen P; Germak J; Rogol AD; Weng W; Kappelgaard AM; Rosenfeld RG;
    J Clin Endocrinol Metab; 2010 May; 95(5):2089-98. PubMed ID: 20207829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost-effectiveness of somatropin treatment for short children born small for gestational age (SGA) and children with growth hormone deficiency (GHD) in Sweden.
    Christensen T; Fidler C; Bentley A; Djurhuus C
    J Med Econ; 2010 Mar; 13(1):168-78. PubMed ID: 20136580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acromegalic features in growth hormone (GH)-deficient patients after long-term GH therapy.
    Carvalho LR; de Faria ME; Osorio MG; Estefan V; Jorge AA; Arnhold IJ; Mendonca BB
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):788-92. PubMed ID: 14974923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
    Abs R; Mattsson AF; Bengtsson BA; Feldt-Rasmussen U; Góth MI; Koltowska-Häggström M; Monson JP; Verhelst J; Wilton P;
    Growth Horm IGF Res; 2005 Oct; 15(5):349-59. PubMed ID: 16168692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.